Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
46.48
+0.77 (1.68%)
At close: Aug 19, 2026, 4:00 PM EDT
46.53
+0.05 (0.11%)
After-hours: Aug 19, 2026, 4:49 PM EDT
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diabetes | 195.86B | 197.00B | 207.11B | 214.33B | 213.12B | 211.73B | 206.62B | 198.11B | |||||||||||||||||||
| Diabetes Growth | -8.10% | -6.96% | 0.24% | 8.19% | 10.57% | 16.05% | 19.11% | 22.93% | |||||||||||||||||||
| Obesity | 87.62B | 84.84B | 82.35B | 81.31B | 79.00B | 72.54B | 65.15B | 54.97B | |||||||||||||||||||
| Obesity Growth | 10.90% | 16.96% | 26.40% | 47.92% | 63.15% | 61.82% | 56.48% | 53.16% | |||||||||||||||||||
| Rare Disease | 19.19B | 19.20B | 19.61B | 19.96B | 19.82B | 18.87B | 18.64B | 17.51B | |||||||||||||||||||
| Rare Disease Growth | -3.15% | 1.75% | 5.20% | 14.05% | 17.73% | 11.21% | 8.60% | 0.34% |
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diabetes and Obesity Care | 141.63B | 146.21B | 126.46B | 131.44B | 140.70B | 134.75B | 127.72B | 117.71B | |||||||||||||||||||
| Diabetes and Obesity Care Growth | 0.67% | 8.51% | -0.99% | 11.67% | 26.80% | 26.31% | 28.20% | 29.95% | |||||||||||||||||||
| Rare Disease | 473.00M | 2.29B | 1.21B | 1.22B | 2.10B | 536.00M | 620.00M | 661.00M | |||||||||||||||||||
| Rare Disease Growth | -77.52% | 326.49% | 95.48% | 83.81% | 317.46% | -80.40% | -78.99% | -71.50% |
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 162.14B | 164.24B | 173.17B | 183.79B | 185.24B | 183.21B | 178.17B | 165.43B | |||||||||||||||||||||||
| North America Growth | -12.47% | -10.36% | -2.81% | 11.10% | 17.33% | 24.96% | 30.41% | 37.09% | |||||||||||||||||||||||
| International | 140.53B | 136.81B | 135.90B | 131.82B | 126.70B | 119.93B | 112.23B | 105.15B | |||||||||||||||||||||||
| International Growth | 10.92% | 14.07% | 21.09% | 25.36% | 26.54% | 22.84% | 17.36% | 12.08% |